| Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|
Variable | p value | HR | 95% CI | p value | HR | 95% CI |
At initial hepatectomy | Â | Â | Â | Â | Â | Â |
 Age (years old) | 0.355 |  |  |  |  |  |
 Gender(male/female) | 0.449 |  |  |  |  |  |
 Positive HBsAg | 0.129 |  |  |  |  |  |
 Positive HBeAg | 0.402 |  |  |  |  |  |
 HBV-DNA | 0.037 | 1.642 | 1.030–2.620 |  |  |  |
 Beyond Milan criteria | 0.098 | 1.467 | 0.932–2.310 |  |  |  |
 Tumor size (cm) | 0.068 | 1.056 | 0.996–1.119 |  |  |  |
 Tumor number | 0.784 |  |  |  |  |  |
 Differentiation(poor/moderate-well) | 0.406 |  |  |  |  |  |
 Microvascular invasion | 0.015 | 1.787 | 1.117–2.860 |  |  |  |
 Satellite lesions | 0.390 |  |  |  |  |  |
 Liver cirrhosis | 0.676 |  |  |  |  |  |
 AFP(> 400 ng/ml) | 0.595 |  |  |  |  |  |
 Recurrence time | 0.003 | 0.975 | 0.959–0.991 | 0.009 | 0.978 | 0.962–0.995 |
 Treatments after recurrence | 0.977 | 0.994 | 0.664–1.488 |  |  |  |
At recurrence time | Â | Â | Â | Â | Â | Â |
 Tumor size (cm) | 0.002 | 1.130 | 1.046–1.222 | 0.001 | 1.149 | 1.062–1.242 |
 Tumor number | 0.016 | 1.426 | 1.067–1.905 |  |  |  |
 Satellite lesions | 0.474 |  |  |  |  |  |
 Macrovascular invasion | 0.003 | 3.367 | 1.529–7.415 |  |  |  |
 Extrahepatic metastasis | 0.016 | 2.363 | 1.174–4.758 |  |  |  |
 AFP(> 400 ng/ml) |  < 0.001 | 2.706 | 1.652–4.433 |  < 0.001 | 2.465 | 1.486–4.089 |
 TBIL(µmol/L) | 0.444 |  |  |  |  |  |
 ALT(U/L) | 0.660 |  |  |  |  |  |
 AST(U/L) | 0.728 |  |  |  |  |  |
 Albumin(g/L) | 0.871 |  |  |  |  |  |
 PLR | 0.016 | 1.005 | 1.001–1.009 |  |  |  |
 NLR | 0.692 |  |  |  |  |  |